25-Mar-2026
No headlines found.
Globe Newswire (Wed, 18-Feb 9:00 AM ET)
Cabot Corporation Reports First Quarter Fiscal Year 2026 Results
Globe Newswire (Tue, 3-Feb 4:30 PM ET)
Cabot Corporation Board Declares Dividend
Globe Newswire (Mon, 2-Feb 4:30 PM ET)
Globe Newswire (Mon, 2-Feb 9:00 AM ET)
Cabot Corporation Demonstrates Continuous Sustainability Progress in CDP Assessment
Globe Newswire (Tue, 13-Jan 9:00 AM ET)
Cabot Corporation to Announce First Quarter Fiscal 2026 Operating Results
Globe Newswire (Fri, 9-Jan 9:28 AM ET)
Globe Newswire (Wed, 7-Jan 9:00 AM ET)
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.
Cabot trades on the NYSE stock market under the symbol CBT.
As of March 25, 2026, CBT stock price climbed to $72.74 with 235,190 million shares trading.
CBT has a beta of 0.77, meaning it tends to be less sensitive to market movements. CBT has a correlation of 0.23 to the broad based SPY ETF.
CBT has a market cap of $3.80 billion. This is considered a Mid Cap stock.
Last quarter Cabot reported $849 million in Revenue and $1.53 earnings per share. This fell short of revenue expectation by $-37 million and exceeded earnings estimates by $.14.
In the last 3 years, CBT traded as high as $117.46 and as low as $58.33.
The top ETF exchange traded funds that CBT belongs to (by Net Assets): AVUV, VTI, IJH, VB, IWM.
CBT has underperformed the market in the last year with a return of -11.3%, while SPY returned +15.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CBT shares. However, CBT has outperformed the market in the last 3 month and 2 week periods, returning +10.7% and +5.8%, while SPY returned -4.6% and -2.7%, respectively. This indicates CBT has been having a stronger performance recently.
CBT support price is $69.04 and resistance is $72.38 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CBT shares will trade within this expected range on the day.
